Invest Now
Samco Star Rating Ads

Glaxosmithkline Pharmaceuticals Ltd Price Performance

  • Day's Low
  • ₹2,270.10
  • Day's High
  • ₹2,339.50
₹ 2,332.55
  • 52-w low
  • ₹1,667.85
  • 52-w high
  • ₹3,088
2,332.55
  • Day's open
    ₹2,285
  • Previous close
    ₹2,264.95
  • VWAP
    ₹2,316.98
  • Lower price band
    ₹1,812
  • Upper price band
    ₹2,717.90

Today's Market Action

The last traded share price of Glaxosmithkline Pharmaceuticals Ltd was 2,332.55 up by 2.98% on the NSE. Its last traded stock price on BSE was 2,334 up by 3.06%. The total volume of shares on NSE and BSE combined was 104,456 shares. Its total combined turnover was Rs 24.20 crores.

Glaxosmithkline Pharmaceuticals Ltd Medium and Long Term Market Action

Glaxosmithkline Pharmaceuticals Ltd hit a 52-week high of 3,088 on 21-08-2024 and a 52-week low of 1,667.85 on 21-12-2023. The stock price of Glaxosmithkline Pharmaceuticals Ltd is down by -3% over the last one month. It is up by 31.54% over the last one year. Don't forget to check the full stock price history in the table below.

Glaxosmithkline Pharmaceuticals Ltd Fundamentals

  • Market Cap (Cr): 41626

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Glaxosmithkline Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Glaxosmithkline Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Glaxosmithkline Pharmaceuticals Ltd

Data not available.

Glaxosmithkline Pharmaceuticals Ltd FAQ's

What is Share Price of Glaxosmithkline Pharmaceuticals Ltd?

What is the Market Cap of Glaxosmithkline Pharmaceuticals Ltd?

What is PE Ratio of Glaxosmithkline Pharmaceuticals Ltd?

What is PB Ratio of Glaxosmithkline Pharmaceuticals Ltd?

What is the CAGR of Glaxosmithkline Pharmaceuticals Ltd?

How to Buy Glaxosmithkline Pharmaceuticals Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 10.44. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.01. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
103
87.50%
87.50% People are bullish about Glaxosmithkline Pharmaceuticals Ltd
12.50%
12.50 % People are bearish about Glaxosmithkline Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Glaxosmithkline Pharmaceuticals Ltd

2,332.55 +67.60 (2.98%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91